Jennifer Tousignant, Chief Legal Officer at Viridian Therapeutics, Inc.\DE, sold VRDN on Aug 19, 2026
Data as of Oct 27
▼ SELL$103K4,212 shares at $24.50Jennifer Tousignant Chief Legal OfficerVRDN Viridian Therapeutics, Inc.\DE
- Traded
- Aug 19, 2026
- Disclosed
- Aug 20, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
VRDN since disclosure
−1.7%
after the sale
Similar stocks (XLV) since disclosure
+3.9%
XLV — its sector index fund
Change in closing price from Aug 20, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJennifer Tousignant Chief Legal OfficerVRDN Viridian Therapeutics, Inc.\DE$245Kdisclosed Aug 20 · filed 1 day after the trade